End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 CNY | -0.56% | -2.41% | -34.47% |
May. 24 | China Approves Menovo Pharma's Type 2 Diabetes Drug | MT |
Apr. 29 | Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Ningbo Menovo Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603538 Stock
- Consensus Ningbo Menovo Pharmaceutical Co., Ltd.